Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

CAPS Rating: 2 out of 5

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

Recs

0
Player Avatar BillZack (< 20) Submitted: 6/26/2012 3:41:16 PM : Underperform Start Price: $67.42 ONXX Score: -4.05

Nice pop, but getting ahead of itself. Extended on any technical chart you want to analyze.

Featured Broker Partners


Advertisement